{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:14:37Z","timestamp":1783379677908,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128397","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:46:40Z","timestamp":1773092800000},"page":"128397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Validation of Guillain-Barr\u00e9 syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria"],"prefix":"10.1016","volume":"78","author":[{"given":"M\u00f2nica","family":"Sabat\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Riera-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ballar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleguer","family":"Par\u00e9s-Badell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Yeomans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Urchuegu\u00eda Fornes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Correcher-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Bissacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Aurelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Clothier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128397_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2026.128397_bb0010","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizalia","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128397_bb0015","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2026.128397_bb0020","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.vaccine.2026.128397_bb0025","author":"UK Government"},{"key":"10.1016\/j.vaccine.2026.128397_bb0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00415-024-12186-7","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19 vaccination: a systematic review and meta-analysis","volume":"271","author":"Censi","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.vaccine.2026.128397_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-barr\u00e9 syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128397_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128397_bb0045","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ana.26218","article-title":"Guillain-Barr\u00e9 syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines","volume":"90","author":"Osowicki","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2026.128397_bb0050","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational global vaccine data network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128397_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127291","article-title":"Risk of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study","volume":"60","author":"Nasreen","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128397_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128397_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2026.128397_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz266","article-title":"Data resource profile: the Valencia health system integrated database (VID)","volume":"49","author":"Garc\u00eda-Sempere","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128397_bb0075","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1093\/ije\/dyac068","article-title":"Data resource profile: the information system for research in primary care (SIDIAP)","volume":"51","author":"Recalde","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128397_bb0080","author":"European medicines Agency (EMA)"},{"key":"10.1016\/j.vaccine.2026.128397_bb0085","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: clinical practice research datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128397_bb0090","series-title":"Vall d\u2019Hebron University Hospital","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128397_bb0095","series-title":"Historia cl\u00ednica compartida presentada en todos los hospitales de la red sanitaria p\u00fablica","author":"Generalitat de Catalunya","year":"2014"},{"key":"10.1016\/j.vaccine.2026.128397_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the vaccine safety datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128397_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10543409508835098","article-title":"On analysis of epidemiological data involving a 2 x 2 contingency table: an overview of fisher\u2019s exact test and yates\u2019 correction for continuity","volume":"5","author":"Sahai","year":"1995","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.vaccine.2026.128397_bb0110","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128397_bb0115","article-title":"Evaluating algorithms for identifying incident Guillain-Barr\u00e9 syndrome in Medicare fee-for-service claims","volume":"7","author":"Eiffert","year":"2024","journal-title":"Glob Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128397_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/CLEP.S199839","article-title":"Guillain-Barr\u00e9 syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period","volume":"11","author":"Levison","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2026.128397_bb0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000369344","article-title":"Estimation of background incidence rates of Guillain-Barr\u00e9 syndrome in Germany - a retrospective cohort study with electronic healthcare data","volume":"43","author":"Hense","year":"2014","journal-title":"Neuroepidemiology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:29:46Z","timestamp":1783376986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":25,"alternative-id":["S0264410X26002057"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128397","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of Guillain-Barr\u00e9 syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128397"}}